You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, January 6, 2016 - 12:00
Condition:   Hypertrophic Obstructive Cardiomyopathy
Intervention:   Drug: Aspirin
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified May 2016
Posted: Monday, December 28, 2015 - 12:00
Condition:   Heart Failure
Interventions:   Procedure: CABG surgery;   Procedure: AADC therapy
Sponsor:   Helsinki University Central Hospital
Not yet recruiting - verified January 2016
Posted: Sunday, December 13, 2015 - 12:00
Condition:   Chronic Ischemic Cardiomyopathy
Interventions:   Biological: hUC-MSCs+Injectable collagen scaffold+CABG;   Biological: hUC-MSCs+CABG;   Procedure: CABG
Sponsors:   Chinese Academy of Sciences;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting - verified December 2015
Posted: Monday, November 30, 2015 - 12:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Standard therapy
Sponsor:   Anterogen Co., Ltd.
Recruiting - verified November 2015
Posted: Sunday, November 22, 2015 - 12:00
Conditions:   Atherosclerosis;   Diabetes;   Restenosis
Interventions:   Drug: Bydureon;   Drug: Humulin kwickpen;   Drug: Metformin
Sponsor:   Karolinska Institutet
Recruiting - verified February 2016
Posted: Thursday, November 12, 2015 - 12:00
Condition:   Stroke
Intervention:   Drug: Intravenous stem cell transplantation
Sponsors:   Southern Medical University, China;   Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified November 2015
Posted: Tuesday, September 29, 2015 - 12:00
Condition:   Stroke
Intervention:   Genetic: Intravenous stem cell transplantation
Sponsors:   Southern Medical University, China;   Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified September 2015
Posted: Tuesday, September 1, 2015 - 12:00
Condition:   Coronary Arteriosclerosis
Interventions:   Device: OrbusNeich Combo stent™;   Device: sirolimus-eluting stent system
Sponsors:   OrbusNeich;   CCRF Inc., Beijing, China;   OrbusNeich Medical (Shenzhen), Co. Ltd.
Recruiting - verified March 2016
Posted: Monday, July 20, 2015 - 12:00
Condition:   Heart Failure
Interventions:   Biological: Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC);   Biological: Placebo
Sponsor:   JKastrup
Recruiting - verified March 2017
Posted: Wednesday, July 15, 2015 - 12:00
Condition:   Ischemic Cardiomyopathy
Interventions:   Biological: Mesenchymal Stem Cells (MSC);   Biological: Cardiac Stem Cells (CSC);   Biological: Placebo (Plasmalyte A)
Sponsors:   The University of Texas Health Science Center, Houston;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2016

Pages